Page last updated: 2024-09-03

cyclazosin and methoxamine

cyclazosin has been researched along with methoxamine in 2 studies

Compound Research Comparison

Studies
(cyclazosin)
Trials
(cyclazosin)
Recent Studies (post-2010)
(cyclazosin)
Studies
(methoxamine)
Trials
(methoxamine)
Recent Studies (post-2010) (methoxamine)
22042,1355782

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angeli, P; Buccioni, M; Giardinà, D; Gulini, U; Marucci, G; Melchiorre, C; Sagratini, G; Testa, R1
Aono, Y; Cools, AR; Koshikawa, N; Saigusa, T; Shimizu, N; Shirakawa, T; Taguchi, H; Takada, K; Takiguchi, H; Uchida, T1

Other Studies

2 other study(ies) available for cyclazosin and methoxamine

ArticleYear
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: functional evaluation in rat and rabbit tissues.
    European journal of pharmacology, 2005, Oct-17, Volume: 522, Issue:1-3

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Binding, Competitive; Clonidine; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Methoxamine; Molecular Structure; Muscle Contraction; Norepinephrine; Quinazolines; Quinoxalines; Rabbits; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Vas Deferens; Vasoconstriction

2005
Simultaneous activation of the α1A-, α1B- and α1D-adrenoceptor subtypes in the nucleus accumbens reduces accumbal dopamine efflux in freely moving rats.
    Behavioural pharmacology, 2015, Volume: 26, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Agonists; Animals; Dopamine; Dose-Response Relationship, Drug; Male; Methoxamine; Microdialysis; Nucleus Accumbens; Piperazines; Quinazolines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1

2015